The sequence analysis of Epstein–Barr virus EBNA1 gene: could viral screening markers for nasopharyngeal carcinoma be identified?
- 85 Downloads
Epstein–Barr virus (EBV) has been identified as a group 1 carcinogenic agent, particularly for nasopharyngeal carcinoma (NPC). The sequence diversity of EBV nuclear antigen 1 (EBNA1) reflects region-restricted polymorphisms, which may be associated with the development of certain malignancies. The aims of the present study were to evaluate EBV EBNA1 gene polymorphisms circulating in NPC, infectious mononucleosis, and isolates from patients with transplanted organs to determine if EBNA1 sequence specificities are useful as viral biomarkers for NPC. Forty biopsies of undifferentiated carcinoma of nasopharyngeal type (UCNT), 31 plasma samples from patients with mononucleosis syndrome, and 16 plasma samples from patients after renal transplantation were tested in this study. The EBNA1 gene was amplified by nested PCR. Further investigation included sequencing, phylogenetic, and statistical evaluations. Eighty-seven sequences were identified as one of the four EBNA1 subtypes, P-Ala, P-Thr, V-Val, and V-Ala, with further classification into ten subvariants. Of these, P-Thr-sv-1 and P-Thr-sv-3 have never been identified in Europe, while V-Val-sv-1 was newly discovered. Statistical analysis revealed significant differences in the distribution of EBNA1 P-Thr subvariants between the three groups of patients, with noticeable clustering of P-Thr-sv-5 in NPC isolates (p < 0.001). EBV EBNA1 showed no sequence specificity in primary infection. This research revealed a newly discovered EBNA1 subvariant. Importantly, EBNA1 P-Thr-sv-5 showed carcinoma-specific EBNA1 variability. Thus, identification of this subvariant should be considered as a viral screening marker for NPC or UCNT.
KeywordsEpstein–Barr virus (EBV) EBNA1 Nasopharyngeal carcinoma Sequence variability Mononucleosis
The authors are grateful to the laboratory technicians Gabrijela Pavlovic and Marija Zivotic from the Virology Department, Institute of Microbiology and Immunology, Faculty of Medicine, University of Belgrade for their technical assistance.
This study was supported by the Ministry of Education, Science and Technological Development, Republic of Serbia, Research Grant no. 175073.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
All procedures performed in study involving human participants were in accordance with the ethical standards of the Ethics Committee of Faculty of Medicine, University of Belgrade no. 29/VI-12 and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For retrospective part of this study, formal consent was not reqired.
- 1.Rickinson AB, Kieff ED (2007) Epstein–Barr virus and its replication. In: Knipe D, Howlry P (eds) Fields virology, 5th edn. Lippincott Williams & Wilkins, Philadelphia, pp 2603–2654Google Scholar
- 3.Rickinson AB, Kieff ED (2013) Epstein–Barr virus. In: Knipe DM, Howley PM, Cohen JI, Griffin DE, Lamb RA, Martin MA et al (ed) Fields virology, 6th edn. Lippincott Williams & Wilkins, Philadelphia, pp 1898–1959Google Scholar
- 8.Bhatia K, Raj A, Guitierrez MI, Judde JG, Spangler G, Venkatesh H et al (1996) Variation in the sequence of Epstein–Barr virus nuclear antigen 1 in normal peripheal blood lymphocytes and in Burkitt’s lymphomas. Oncogene 13:177–181Google Scholar
- 9.Sandvej K, Zhou XG, Hamilton-Dutoit S (2000) EBNA-1 sequence variation in Danish and Chinese EBV-associated tumors: evidence for geographical polymorphism but not for tumor-specific subtype restriction. J Pathol 191:127–131. https://doi.org/10.1002/(SICI)1096-9896(200006)191:2%3C127::AID-PATH614%3E3.0.CO;2-E CrossRefGoogle Scholar
- 11.Tschochner M, Leary S, Cooper D, Strautins K, Chopra A, Clark H et al (2016) Identifying patient-specific epstein–barr nuclear antigen-1 genetic variation and potential autoreactive targets relevant to multiple sclerosis pathogenesis. PLoS One. https://doi.org/10.1371/journal.pone.0147567 Google Scholar
- 13.Lorenzetti MA, Altcheh J, Moroni S, Moscatelli G, Chabay PA, Preciado MV (2010) EBNA1 sequences in Argentinean pediatric acute and latent Epstein–Barr virus infection reflect circulation of novel South American variants. J Med Virol 82:1730–1738. https://doi.org/10.1002/jmv.21871 CrossRefGoogle Scholar
- 14.Hall TA (1999) BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95, 98, NT, 2000, XP. Nucl Acids Symp 41:95–98Google Scholar
- 18.Rambaut A (2007) Molecular evolution, phylogenetics and epidemiology. http://tree.bio.ed.ac.uk/software/figtree/. Accessed 27 Nov 2015
- 19.Chen YY, Chang KL, Chen WG, Shibada D, Hayashi K, Weiss LM (1998) Epstein–Barr virus-associated nuclear antigen-1 carboxy-terminal gene sequences in Japanese and American patients with gastric carcinoma. Lab Investig 78:877–882Google Scholar
- 20.MacKenzie J, Gray D, Pinto-Paes R, Barrezueta LF, Armstrong AA, Alexander FA et al (1999) Analysis of Epstein–Barr virus (EBV) nuclear antigen 1 subtypes in EBV-associated lymphomas from Brasil and the United Kingdom. J Gen Virol 80:2741–2745. https://doi.org/10.1099/0022-1317-80-10-2741 CrossRefGoogle Scholar